1 Min Read
March 8 (Reuters) - Clovis Oncology Inc:
* CLOVIS ONCOLOGY ANNOUNCES NOTICE OF ALLOWANCE FOR RUCAPARIB HIGH DOSAGE STRENGTH TABLET PATENT WITH EXPIRATION IN 2035 Source text for Eikon: Further company coverage:
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2018 Reuters. All Rights Reserved.